What is the mean terminal elimination half-life of oritavancin diphosphate in patients with acute bacterial skin and skin structure infections?

Oritavancin diphosphate has a mean terminal elimination plasma half-life of 245 hours (14.9% coefficient of variation), based on population pharmacokinetic analysis of patients with acute bacterial skin and skin structure infections receiving a single 1200 mg dose.